Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Weishi Li is a partner in the firm's Shanghai office.  Her practice covers a wide range of technology-related transactions across multiple sectors, including the life sciences and hi-tech industries.  She has extensive experience assisting multinational companies and Chinese companies in structuring and negotiating cross-border transactions with a significant intellectual property element, such as technology joint ventures and strategic alliances.

Ms. Li has particular expertise in the life sciences sector, having assisted many western and Chinese life sciences companies in structuring and negotiating commercial, corporate and partnering transactions in China, including strategic collaborations, joint ventures, licensing, acquisitions, co-promotion and distribution arrangements.

  • China Business Law Journal, Greater China: A-List Top 100 Lawyers (2016)  
  • Chambers Asia-Pacific, China: Life Sciences (International Firms, Band 1) (2012-2019)   
  • Chambers Global, China: Global-Wide: Life Sciences (2014-2016)
  • Asia IP Experts, Licensing & Franchise; Pharma & Biotech (2014, 2017)    
  • The International Who's Who of Life Sciences Lawyers (2011-2015)
  • IAM Patent 1000, The World's Leading Patent & Technology Licensing Lawyers
  • IAM Licensing 250, The World's Leading Patent & Technology Licensing Lawyers